Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Blood (2019) 134 (Supplement_1): 3034.

https://doi.org/10.1182/blood-2019-128850

Published: 2019

Journal Articles

Delayed Diagnosis of Anemia in Late Pregnancy: Consequences at Delivery and Unintended Effects of Third Trimester HIV Screening Policy

Nikil V Moodabagil, MD, Sarah Scheiderich Osmundson, MD, Christian Cepeda, BS Candidate, Colleen Morton, MD

Blood (2019) 134 (Supplement_1): 4675.

https://doi.org/10.1182/blood-2019-124910

Published: 2019

Journal Articles

Fetal Hemoglobin Level during Hydroxyurea Therapy Varies By Neighborhood

Jason R Hodges, PhD MA, Martha Villavicencio, PhD, Jeremie H. Estepp, MD, Jane S. Hankins, MD MS

Blood (2018) 132 (Supplement 1): 2221.

https://doi.org/10.1182/blood-2018-99-119165

Published: 2018

Journal Articles

Initial Report of a Serum Assay to Predict Amyloid Risk in Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance

Emily B. Martin, PhD, Angela Williams, MS, R. Eric Heidel, PhD, Ronald H. Lands, MD, Stephen J. Kennel, PhD, Angela Dispenzieri, MD, Jonathan S. Wall, PhD

Blood (2017) 130 (Supplement 1): 5371.

https://doi.org/10.1182/blood.V130.Suppl_1.5371.5371

Published: 2017

Journal Articles

Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

Camille Vanessa Edwards, MBBS, BSc, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Y Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Siyang Leng, MD, Jonathan S. Wall, PhD, Andrew Eisenberger, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD

Blood (2017) 130 (Supplement 1): 509.

https://doi.org/10.1182/blood.V130.Suppl_1.509.509

Published: 2017

Journal Articles

A Method to Identify Patients with Multiple Myeloma Who Are at Risk of Developing Concomitant Amyloidosis

Emily B. Martin, PhD, Angela Williams, MS, R. Eric Heidel, PhD, Ronald H. Lands, MD, Stephen J. Kennel, PhD, Jonathan S. Wall, PhD

Blood (2017) 130 (Supplement 1): 4339.

https://doi.org/10.1182/blood.V130.Suppl_1.4339.4339

Published: 2017

Journal Articles

Direct Evidence of Complement Activation in HELLP Syndrome: A Link to Atypical Hemolytic Uremic Syndrome

Eleni Gavriilaki, MD, Arthur Vaught, Nancy Heuppchen, Karin Blakemore, Xuan Yuan, MD MSc, Sara Seifert, Sara York, Robert A. Brodsky, MD

Blood (2015) 126 (23): 1047.

https://doi.org/10.1182/blood.V126.23.1047.1047

Published: 2015

Journal Articles

Numerical Analysis Of Platelet Turnover Data Demonstrates Reduced Or Near-Baseline Platelet Production Rates In 90% Of Corticosteroid Non-Responsive Immune Thrombocytopenic Purpura (ITP) Patients

Ted Strom, MD, PhD, Nuria Pujol-Moix, MD

Blood (2013) 122 (21): 3532.

https://doi.org/10.1182/blood.V122.21.3532.3532

Published: 2013

Journal Articles

Plasma Exchange Is Not Necessary For The Treatment Of Microangiopathic Hemolytic Anemia Due To Intravenous Opana Abuse

Peter J. Miller, MD, Andrew M. Farland, MD, Mary Ann Knovich, MD, John Owen, MD, MBA, FRCPC, FACP

Blood (2013) 122 (21): 2322.

https://doi.org/10.1182/blood.V122.21.2322.2322

Published: 2013

Journal Articles

Outpatient Visits, Hospitalizations and Emergency Department Visits Among Patients with Sickle Cell Disease On Medicaid: Trends in 14 USA States, 2006–2007.

Benjamin Ansa, MD, Tom Adamkiewicz, MD, MSCR, FRCP(C), Yvonne Fry-Johnson, MD, MSCR, Gregory Strayhorn, MD, PhD, Barbara Moore, George S Rust, MD, MPH

Blood (2012) 120 (21): 3181.

https://doi.org/10.1182/blood.V120.21.3181.3181

Published: 2012

Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH

Blood (2012) 120 (21): 2106.

https://doi.org/10.1182/blood.V120.21.2106.2106

Published: 2012

Journal Articles

Demographic and Socio-Economic Features of a Cohort of Adult Sickle Cell Disease Patients.

Syed N Haider, MD, Jun Tang, MS, Phd, Raymond U. Osarogiagbon, MBBS

Blood (2009) 114 (22): 4616.

https://doi.org/10.1182/blood.V114.22.4616.4616

Published: 2009

Journal Articles

Acute Care Visits in Sickle Cell Disease: a Population-Based Multi- State Study

David Brousseau, MD, MS, Julie A. Panepinto, MD, MSPH, Pamela Owens, PhD, Claudia Steiner, MD, MPH

Blood (2008) 112 (11): 165.

https://doi.org/10.1182/blood.V112.11.165.165

Published: 2008

Journal Articles

The Prevalence of Renal Dysfunction in Young Adults with Sickle Cell Disease.

Raymond U. Osarogiagbon, MBBS, FACP, Laura M. McHugh, RN, Lori E. Kronish, BSN, Elisabeth A. Chismark, RN, MSN

Blood (2007) 110 (11): 3804.

https://doi.org/10.1182/blood.V110.11.3804.3804

Published: 2007

Journal Articles

Variability in Measures of Health Outcomes in Sickle Cell Disease (SCD) Patients with Access to Comprehensive Care Centers.

Sadhna M. Shankar, MD, MPH, Patrick Abrogast, Ph.D, Ed Mitchel, MS, Hua Ding, MS, Winfred Wang, MD, Marie R. Griffin, MD, MPH

Blood (2005) 106 (11): 294.

https://doi.org/10.1182/blood.V106.11.294.294

Published: 2005

NARROW

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Delayed Diagnosis of Anemia in Late Pregnancy: Consequences at Delivery and Unintended Effects of Third Trimester HIV Screening Policy

Fetal Hemoglobin Level during Hydroxyurea Therapy Varies By Neighborhood

Initial Report of a Serum Assay to Predict Amyloid Risk in Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance

Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

A Method to Identify Patients with Multiple Myeloma Who Are at Risk of Developing Concomitant Amyloidosis

Direct Evidence of Complement Activation in HELLP Syndrome: A Link to Atypical Hemolytic Uremic Syndrome

Numerical Analysis Of Platelet Turnover Data Demonstrates Reduced Or Near-Baseline Platelet Production Rates In 90% Of Corticosteroid Non-Responsive Immune Thrombocytopenic Purpura (ITP) Patients

Plasma Exchange Is Not Necessary For The Treatment Of Microangiopathic Hemolytic Anemia Due To Intravenous Opana Abuse

Outpatient Visits, Hospitalizations and Emergency Department Visits Among Patients with Sickle Cell Disease On Medicaid: Trends in 14 USA States, 2006–2007.

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Demographic and Socio-Economic Features of a Cohort of Adult Sickle Cell Disease Patients.

Acute Care Visits in Sickle Cell Disease: a Population-Based Multi- State Study

The Prevalence of Renal Dysfunction in Young Adults with Sickle Cell Disease.

Variability in Measures of Health Outcomes in Sickle Cell Disease (SCD) Patients with Access to Comprehensive Care Centers.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only